MiR-203a functions as a tumor suppressor in bladder cancer by targeting SIX4

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) regulate crucial cellular functions like proliferation and apoptosis.
• Dysregulation of miRNAs contributes to cancer progression and metastasis.
• MiR-203a acts as a tumor suppressor in several cancers, including glioma and gastric cancer.

Purpose of the Study:

• To investigate the role of miR-203a in bladder cancer.
• To determine the correlation between miR-203a expression and patient prognosis.
• To identify the molecular mechanisms underlying miR-203a's function in bladder cancer.

Main Methods:

• Quantitative real-time PCR to measure miR-203a expression in bladder cancer tissues.
• In vitro assays to assess the effects of miR-203a overexpression on cell proliferation, invasion, migration, EMT, cell cycle, and apoptosis.
• Bioinformatics prediction and luciferase reporter assays to identify miR-203a targets.
• Western blotting to analyze protein expression, including the PI3K/Akt pathway and SIX4.

Main Results:

• miR-203a expression was significantly lower in bladder cancer tissues compared to normal tissues.
• Low miR-203a expression correlated with poor patient outcomes.
• miR-203a overexpression inhibited bladder cancer cell proliferation, invasion, migration, and EMT, inducing cell cycle arrest and apoptosis.
• miR-203a inhibited the PI3K/Akt signaling pathway.
• SIX4 was identified as a direct target of miR-203a, with inverse expression correlation in tumor tissues.
• SIX4 silencing mimicked miR-203a upregulation effects, and SIX4 overexpression counteracted miR-203a's inhibitory effects.

Conclusions:

• miR-203a downregulation is linked to bladder cancer development.
• miR-203a functions as a tumor suppressor in bladder cancer by targeting SIX4 and inhibiting the PI3K/Akt pathway.
• miR-203a holds potential as a prognostic biomarker and therapeutic target for bladder cancer.